Meanwhile, antidepressant drugs may exert beneficial effects on the insulin receptor phosphorylation pathway through the Shc1/Grb2 complex (50), which further supports the potential use of Sch1 for depression drug development. This evidence concerns the gene SHC1 and depressive disorder.